Free Trial

Aurinia Pharmaceuticals (AUPH) Insider Trading & Ownership

Aurinia Pharmaceuticals logo
$8.24 +0.11 (+1.35%)
(As of 11/20/2024 ET)

Aurinia Pharmaceuticals (NASDAQ:AUPH) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.30%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$135,317.70
Get AUPH Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aurinia Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AUPH Insider Buying and Selling by Quarter

Aurinia Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/11/2024Jeffrey Allen BaileyDirectorSell4,557$8.43$38,415.51  
8/6/2024Scott Michael HabigInsiderSell18,249$5.31$96,902.19  
(Data available from 1/1/2013 forward)

AUPH Insider Trading Activity - Frequently Asked Questions

The list of insiders at Aurinia Pharmaceuticals includes David R.W. Jayne, George M Milne Jr, Jeffrey Allen Bailey, Jill Leversage, Joseph M Miller, Joseph P Hagan, Peter Greenleaf, Scott Michael Habig, and Stephen P Robertson. Learn more on insiders at AUPH.

4.30% of Aurinia Pharmaceuticals stock is owned by insiders. Learn more on AUPH's insider holdings.

The following insider purchased AUPH shares in the last 24 months: George M Milne Jr ($178,200.00).

Insiders have purchased a total of 20,000 AUPH shares in the last 24 months for a total of $178,200.00 bought.

The following insiders have sold AUPH shares in the last 24 months: David R.W. Jayne ($98,333.58), Jeffrey Allen Bailey ($38,415.51), Joseph M Miller ($100,986.24), Joseph P Hagan ($2,877.76), Peter Greenleaf ($292,785.00), Scott Michael Habig ($96,902.19), and Stephen P Robertson ($173,453.88).

Insiders have sold a total of 95,259 Aurinia Pharmaceuticals shares in the last 24 months for a total of $803,754.16 sold.

Aurinia Pharmaceuticals Key Executives



This page (NASDAQ:AUPH) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners